Scientists debunked the belief that breast cancer is always viral with the mid-90s discovery of the first hereditary genetic mutation linked to a significantly higher-than average chance of breast and ovarian cancer. This genetic condition, called Hereditary Breast and Ovarian Cancer (HBOC), passes the mutation from generation to generation in a family. Thousands of variations of such mutations exist, and carriers account for 10 to 15% of all breast cancer, and up to 20% of ovarian (Childers et al., 2017). In addition, genetic testing uncovered a rapidly rising number of healthy people (never had breast/ovarian cancer) who are also carriers, flooding healthcare providers seeking potential options to reduce their elevated risk. Those prophyl...
Rationale: Women with a harmful mutation in the BReast CAncer (BRCA) gene are at significantly incre...
BACKGROUND: Many cancer-patients undergo DNA testing in the BRCA1/2 genes to receive information abo...
Children\u27s literacy about the genetics of late-onset hereditary breast/ovarian cancer (HBOC) ofte...
The recent identification of Breast Cancer 1 (BRCA1) and BRCA2 genes offers an opportunity for high-...
This thesis questions whether the experiences of women at-risk of hereditary breast and ovarian canc...
Breast cancer accounts for one third of all female cancer cases worldwide. A hereditary component ac...
This study examined the influence of genetic testing for hereditary breast/ovarian cancer on indivi...
Purpose/Objectives: To (a) examine differences in appraisals of hereditary breast and ovarian cancer...
Background: When women from families with a known BRCA1 or BRCA2 mutation test negative for the fami...
Research suggests that a significant proportion of individuals from families at risk of hereditary ...
Hereditary breast and/or ovarian cancer (HBOC) accounts for 5-10% of all breast and ovarian cancer d...
Breast cancer is the most common malignancy affecting females globally. Hereditary breast and ovaria...
This study sought to examine changes in psychological distress following cancer genetic counselling....
Advances in science and genomic medicine are leading to more discoveries of genetic variations assoc...
Background: It has been hypothesized that the Outcomes of DNA testing (O) are better predicted and/o...
Rationale: Women with a harmful mutation in the BReast CAncer (BRCA) gene are at significantly incre...
BACKGROUND: Many cancer-patients undergo DNA testing in the BRCA1/2 genes to receive information abo...
Children\u27s literacy about the genetics of late-onset hereditary breast/ovarian cancer (HBOC) ofte...
The recent identification of Breast Cancer 1 (BRCA1) and BRCA2 genes offers an opportunity for high-...
This thesis questions whether the experiences of women at-risk of hereditary breast and ovarian canc...
Breast cancer accounts for one third of all female cancer cases worldwide. A hereditary component ac...
This study examined the influence of genetic testing for hereditary breast/ovarian cancer on indivi...
Purpose/Objectives: To (a) examine differences in appraisals of hereditary breast and ovarian cancer...
Background: When women from families with a known BRCA1 or BRCA2 mutation test negative for the fami...
Research suggests that a significant proportion of individuals from families at risk of hereditary ...
Hereditary breast and/or ovarian cancer (HBOC) accounts for 5-10% of all breast and ovarian cancer d...
Breast cancer is the most common malignancy affecting females globally. Hereditary breast and ovaria...
This study sought to examine changes in psychological distress following cancer genetic counselling....
Advances in science and genomic medicine are leading to more discoveries of genetic variations assoc...
Background: It has been hypothesized that the Outcomes of DNA testing (O) are better predicted and/o...
Rationale: Women with a harmful mutation in the BReast CAncer (BRCA) gene are at significantly incre...
BACKGROUND: Many cancer-patients undergo DNA testing in the BRCA1/2 genes to receive information abo...
Children\u27s literacy about the genetics of late-onset hereditary breast/ovarian cancer (HBOC) ofte...